Table 2 Transcription factors significantly enriched for predicted deleterious de novo variants
Gene | LOEUF | de novo variants | Inherited variants | de novo and case/control q value | de novo only q value | |||
---|---|---|---|---|---|---|---|---|
pLoF | MisA | MisB | Case pLoF | Control pLoF | ||||
Congenital heart defect | ||||||||
GATA6 | 0.174 | 3 | 2 | 0 | 0 | 0 | 2.5 × 10−5 | 3.5 × 10−6 |
KMT2A | 0.065 | 5 | 0 | 1 | 0 | 0 | 3.2 × 10−4 | 5.0 × 10−5 |
ADNP | 0.123 | 4 | 0 | 0 | 0 | 1 | 5.8 × 10−4 | 3.1 × 10−4 |
KDM5Ba | 0.572 | 4 | 0 | 0 | 2 | 4 | 0.012159 | 5.2 × 10−4 |
NR2F2 | 0.217 | 2 | 1 | 0 | 0 | 0 | 0.014122 | 0.002103 |
FOXP1a | 0.175 | 2 | 1 | 0 | 0 | 0 | 0.029404 | 0.003100 |
TBX5 | 0.135 | 1 | 1 | 0 | 1 | 0 | 0.031389 | 0.053298 |
GATA4 | 0.527 | 2 | 0 | 0 | 2 | 1 | 0.040077 | 0.050796 |
TCF12 | 0.372 | 1 | 1 | 0 | 2 | 1 | 0.051542 | 0.068473 |
ZEB2 | 0.107 | 1 | 1 | 0 | 1 | 0 | 0.058741 | 0.131609 |
KLF2a | 0.710 | 1 | 1 | 0 | 0 | 0 | 0.204573 | 0.032261 |
SMAD4 | 0.222 | 0 | 2 | 0 | 0 | 0 | 0.209108 | 0.035057 |
MEIS2a | 0.184 | 2 | 0 | 0 | 0 | 0 | 0.271015 | 0.055872 |
CTCFa | 0.148 | 0 | 2 | 0 | 0 | 0 | 0.278293 | 0.058374 |
Orofacial cleft | ||||||||
SATB2 | 0.091 | 7 | 5 | 0 | 0 | 0 | 3.86 × 10−14 | 5.77 × 10−15 |
TFAP2A | 0.261 | 2 | 3 | 0 | 1 | 0 | 2.84 × 10−6 | 7.70 × 10−6 |
CTCF | 0.148 | 0 | 3 | 0 | 0 | 0 | 0.011737 | 0.001484 |
IRF6 | 0.132 | 1 | 0 | 3 | 1 | 0 | 0.002951 | 0.007637 |
TP63 | 0.267 | 1 | 1 | 0 | 3 | 0 | 0.003631 | 0.072430 |
SOX5b | 0.188 | 1 | 1 | 0 | 1 | 0 | 0.018728 | 0.058691 |
ADNPb | 0.123 | 2 | 0 | 0 | 0 | 1 | 0.092444 | 0.088307 |
GRHL2b | 0.270 | 2 | 0 | 0 | 0 | 0 | 0.328840 | 0.076571 |